PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

The burden of babesiosis disease was significantly worse among patients with vs without immunocompromising conditions.

Patients with AUD in the ICU exhibited high rates of infection, complications, morbidity, and in-hospital mortality.

As case numbers rise, public health officials are warning of yet another difficult year of battling pertussis infections.